SAB Biotherapeutics Inc (SABS): Eigentümerstruktur
Der letzte verfügbare Schlusskurs ist 24.07.2026. Die angezeigten Informationen beziehen sich auf den historischen Stand und sind nicht tagesaktuell.
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 11,182 US Dollar | 4 | 1 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 76.464.094 | 5,94 | 3,68 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name SAB Biotherapeutics Inc
Mitarbeiter 86
Handelsplatz NASDAQ
Ticker Symbol SABS
IPO Datum 2021-02-09
Adresse 777 W 41st St., Miami Beach, FL, United States, 33140
Webseite https://www.sab.bio
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Samuel J. Reich | CEO & Director |
| 2 | Dr. Eddie Joe Sullivan Ph.D. | Co-Founder, President & Director |
| 3 | Ms. Lucy To | Executive VP & CFO |
| 4 | Dr. Christoph Bausch M.B.A., Ph.D. | Executive VP & COO |
| 5 | Dr. Alexandra Kropotova M.B.A., M.D. | Executive VP & Chief Medical Officer |
| 6 | Ms. Cristi Barnett | Vice President of Investor Relations & Corporate Communications |
| 7 | Ms. Catherine DeRose | Vice President of Human Resources |
| 8 | Ms. Hua Wu Ph.D. | Senior Vice President of Product Development |
| 9 | Dr. Carlos N. Carillo M.Sc., Ph.D. | Senior Vice President of Regulatory Affairs |
| 10 | Ms. Angie Parizek | Senior Vice President of Clinical Operations |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Vivo Capital, LLC | 14,94% | 40,08 Mio. USD |
| 2 | Caligan Partners LP | 10,42% | 27,97 Mio. USD |
| 3 | Perceptive Advisors LLC | 8,41% | 22,58 Mio. USD |
| 4 | COMMODORE CAPITAL LP | 5,76% | 15,45 Mio. USD |
| 5 | RA Capital Management, LLC | 5,76% | 15,45 Mio. USD |
| 6 | Balyasny Asset Management LLC | 4,92% | 13,20 Mio. USD |
| 7 | Adage Capital Partners Gp LLC | 4,45% | 11,95 Mio. USD |
| 8 | Millennium Management LLC | 3,97% | 10,65 Mio. USD |
| 9 | Woodline Partners LP | 3,73% | 10,01 Mio. USD |
| 10 | Vanguard Capital Management, LLC | 3,26% | 8,75 Mio. USD |
| 11 | Spruce Street Capital LP | 2,88% | 7,72 Mio. USD |
| 12 | Sessa Capital, L.P | 2,88% | 7,72 Mio. USD |
| 13 | Vanguard Group Inc | 2,42% | 6,48 Mio. USD |
| 14 | BOOTHBAY FUND MANAGEMENT, LLC | 1,94% | 5,20 Mio. USD |
| 15 | Ameriprise Financial Inc | 1,93% | 5,18 Mio. USD |
| 16 | Ensign Peak Advisors Inc | 1,80% | 4,83 Mio. USD |
| 17 | Soleus Capital Management, L.P. | 1,37% | 3,69 Mio. USD |
| 18 | Propel Bio Management LLC | 1,32% | 3,56 Mio. USD |
| 19 | Jefferies Financial Group Inc | 1,18% | 3,17 Mio. USD |
| 20 | Blackstone Inc | 1,12% | 3,02 Mio. USD |